TB R&D Weekly Update: Podcast Interview with Eric Nuermberger
In this week''s TB R&D update, the WGND had the opportunity to talk with Dr. Nuermberger on a recent article entitled "PA-824 exhibits time-dependent activity in a murine model of tuberculosis"...
View ArticleTB R&D Weekly Update: Podcast interview on TB Drug Tolerance and Efflux Pumps
The WGND had the opportunity to interview three researchers (Lalita Ramakrishnan, Paul Edelstein, and Christine Cosma) involved in the groundbreaking research on the role of efflux pumps in...
View ArticleTB R&D Weekly Update: Podcast Interview with Dr. Edward Nardell
This week, we feature an interview with Dr. Edward Nardell who is a pulmonologist with a special interest in tuberculosis. His principal academic appointment is as associate professor of medicine,...
View ArticleTB R&D Weekly Update: T-Cell Surface Markers as Potential Biomarkers for TB...
In this week's article, potential cellular biomarkers are explored in the mouse model with three potential markers: PD-1 and TIM-3 on CD8 T cells and KIRG-1 on both CD4 and CD8 T cells. The search for...
View ArticleTB R&D Weekly Update: TB Drug Updates in Future Medicinal Chemistry
Last week we posted information about two special issues of Future Medicinal Chemistry focused on neglected diseases. Future Medicinal Chemistry (September 2011, Volume 3, Number 11) have a few...
View ArticleTB R&D Weekly Update: ICAAC and TB Drug Clinical Workshop
On September 16, the 4th International Workshop on Clinical Pharmacology of Tuberculosis Drugs was held adjacent to the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) which...
View ArticleInternational TB Research Roadmap Launched!
A plan targeting researchers around the world and providing them with a framework to achieve the research objectives of the the Global Plan to Stop TB 2011-2015 and beyond, towards elimination of TB,...
View ArticleTB R&D Weekly Update: Tailoring TB Treatment Based on Host Genotype?
This week we have research out of the Ramakrishnan Laboratory that challenges thinking around tuberculosis treatment and considerations of host genotypes. Additional links to TB R&D news are included.
View ArticleImmunotherapeutic Vaccines, TB and China: Interview with Dr. Douglas Lowrie
This week we highlight an interview with Dr. Douglas Lowrie, a Senior Research Fellow at Fudan University's Shanghai Public Health Clinical Center in China. He discusses the extent of the problem of TB...
View ArticleJID Journal Supplement: Tuberculosis Drug Development
A supplement dedicated to TB drug development appears in the Journal of Infectious Diseases Volume 211, June 15, 2015. Topics include nonclinical models of TB drug development, PKPD and dose response,...
View Article
